DE60105977D1 - Auf lipiden basierende systeme zur arzneistoffabgabe - Google Patents

Auf lipiden basierende systeme zur arzneistoffabgabe

Info

Publication number
DE60105977D1
DE60105977D1 DE60105977T DE60105977T DE60105977D1 DE 60105977 D1 DE60105977 D1 DE 60105977D1 DE 60105977 T DE60105977 T DE 60105977T DE 60105977 T DE60105977 T DE 60105977T DE 60105977 D1 DE60105977 D1 DE 60105977D1
Authority
DE
Germany
Prior art keywords
lipid
drug delivery
based systems
carbon atoms
organic radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60105977T
Other languages
English (en)
Other versions
DE60105977T2 (de
Inventor
Kent Joergensen
Jesper Davidsen
Charlotte Vermehren
Sven Froekjaer
G Mouritsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liplasome Pharma ApS
Original Assignee
Liplasome Pharma ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liplasome Pharma ApS filed Critical Liplasome Pharma ApS
Publication of DE60105977D1 publication Critical patent/DE60105977D1/de
Application granted granted Critical
Publication of DE60105977T2 publication Critical patent/DE60105977T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60105977T 2000-02-10 2001-02-09 Auf lipiden basierende systeme zur arzneistoffabgabe Expired - Lifetime DE60105977T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK200000211 2000-02-10
DKPA200000211 2000-02-10
DKPA200000616 2000-04-12
DK200000616 2000-04-12
PCT/DK2001/000092 WO2001058910A2 (en) 2000-02-10 2001-02-09 Lipid-based drug delivery systems

Publications (2)

Publication Number Publication Date
DE60105977D1 true DE60105977D1 (de) 2004-11-04
DE60105977T2 DE60105977T2 (de) 2006-02-23

Family

ID=26068763

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60105977T Expired - Lifetime DE60105977T2 (de) 2000-02-10 2001-02-09 Auf lipiden basierende systeme zur arzneistoffabgabe

Country Status (9)

Country Link
EP (2) EP1254143B1 (de)
JP (1) JP2003522193A (de)
AT (1) ATE277935T1 (de)
AU (1) AU778659B2 (de)
CA (1) CA2399821A1 (de)
DE (1) DE60105977T2 (de)
ES (1) ES2230268T3 (de)
PT (1) PT1254143E (de)
WO (1) WO2001058910A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4778679B2 (ja) * 2001-10-03 2011-09-21 セレーター ファーマシューティカルズ インコーポレイテッド 併用薬剤を送達するための組成物
US7850990B2 (en) 2001-10-03 2010-12-14 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
CA2383259A1 (en) 2002-04-23 2003-10-23 Celator Technologies Inc. Synergistic compositions
WO2006048017A1 (en) * 2004-11-03 2006-05-11 Liplasome Pharma A/S Lipid-based drug delivery systems containing unnatural phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof
WO2006086992A2 (en) * 2005-02-18 2006-08-24 Liplasome Pharma A/S Drug delivery systems containing phqspholipase a2 degradable lipid prodrug derivatives and the therapeutic uses thereof as. e.g. wound healing agents and peroxisome proliferator activated receptor ligands
WO2007041206A2 (en) * 2005-09-30 2007-04-12 Auburn University Drug delivery nanocarriers targeted by landscape phage
CA2647779A1 (en) * 2006-03-23 2007-09-27 Liplasome Pharma A/S Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis
EP2123258A1 (de) 2008-05-23 2009-11-25 Liplasome Pharma A/S Liposomen zur Arzneimittelverabreichung
DK177532B1 (en) * 2009-09-17 2013-09-08 Bio Bedst Aps Medical use of sPLA2 hydrolysable liposomes
DK177529B1 (en) 2009-10-23 2013-09-08 Bio Bedst Aps Liposomes with improved storage stability
EP2343310A1 (de) 2010-01-08 2011-07-13 Novozymes A/S Serinhydrolaseformulierung
WO2011098578A2 (en) 2010-02-12 2011-08-18 Bioneer A/S Liposome system for ocular administration
CZ308596B6 (cs) * 2017-04-03 2020-12-23 Ústav molekulární genetiky AV ČR, v. v. i. Deriváty fosfolipidů a jejich použití jako léčiva
EP3530265A1 (de) * 2018-02-27 2019-08-28 LipoCoat B.V. Universelles verfahren zur herstellung von lipidbasierten beschichtungen
EP3530266A1 (de) * 2018-02-27 2019-08-28 LipoCoat B.V. Lipidbasierte beschichtungszusammensetzung und objekt mit einer lipidbasierten beschichtung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4622392A (en) * 1984-06-21 1986-11-11 Health Research Inc. (Roswell Park Division) Thiophospholipid conjugates of antitumor agents
US5153000A (en) * 1988-11-22 1992-10-06 Kao Corporation Phosphate, liposome comprising the phosphate as membrane constituent, and cosmetic and liposome preparation comprising the liposome
DE4408011C1 (de) * 1994-03-10 1995-11-02 Max Delbrueck Centrum Pharmazeutisches Mittel zur Tumortherapie
US5817856A (en) * 1995-12-11 1998-10-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Radiation-protective phospholipid and method
US5827836A (en) * 1996-11-15 1998-10-27 Clarion Pharmaceuticals Inc. Retinoid glycerol phospholipid conjugates
US6200598B1 (en) * 1998-06-18 2001-03-13 Duke University Temperature-sensitive liposomal formulation

Also Published As

Publication number Publication date
WO2001058910A2 (en) 2001-08-16
ES2230268T3 (es) 2005-05-01
EP1254143B1 (de) 2004-09-29
JP2003522193A (ja) 2003-07-22
ATE277935T1 (de) 2004-10-15
WO2001058910A3 (en) 2002-02-21
EP1254143A2 (de) 2002-11-06
EP1484332A2 (de) 2004-12-08
PT1254143E (pt) 2005-02-28
DE60105977T2 (de) 2006-02-23
CA2399821A1 (en) 2001-08-16
AU778659B2 (en) 2004-12-16
EP1484332A3 (de) 2009-01-21
AU3153301A (en) 2001-08-20

Similar Documents

Publication Publication Date Title
DE60105977D1 (de) Auf lipiden basierende systeme zur arzneistoffabgabe
AR025444A1 (es) Derivados de sulfonil-carboxamida, procedimientos para su preparacion y su utilizacion como medicamentos
BR0110316A (pt) Composições únicas de fosfolipìdios e bisfosfonatos zwitteriÈnicos e uso das composições como sistemas de distribuição de bisfosfatos com toxicidade gi reduzida
WO2006048017A8 (en) Lipid-based drug delivery systems containing unnatural phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof
BRPI0418133A2 (pt) pró-fármaco de florfenicol tendo solubilidade em água melhorada
NZ527157A (en) Compositions for delivering bisphosphonates
MXPA01008937A (es) Nuevos profarmacos que contienen fosforo.
IT1281193B1 (it) Composizioni farmaceutiche contenenti 2,6 diisopropilfenolo (propofol) e metodo per la loro preparazione
WO2000009531A3 (en) β-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B
BR0316315A (pt) Dispositivo conector
MX9306303A (es) Derivados de acidos carboxilicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion.
BR0111806A (pt) Método de administração de bisfosfonatos
AR009911A1 (es) Derivados de acido benzazepinona-n-acetico, sustituidos con acidos fosfonicos, asi como procedimientos para su preparacion y medicamentos que contienen estos compuestos
ATE453380T1 (de) Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen
IL175573A0 (en) Vaccine composition admixed with an alkylphosphatidylcholine
BR0016179A (pt) Método para preparar lisofosfatidiletanolamina
WO2008093772A1 (ja) 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤
NZ325259A (en) Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments
MXPA02008270A (es) Transportador de lipidos.
WO2007107161A8 (en) Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis
WO2006086992A3 (en) Drug delivery systems containing phqspholipase a2 degradable lipid prodrug derivatives and the therapeutic uses thereof as. e.g. wound healing agents and peroxisome proliferator activated receptor ligands
BRPI0407818A (pt) sistema de distribuição subcutánea, processo para a preparação do mesmo e uso do mesmo para o tratamento das doenças da deficiência colinérgica
AR022735A1 (es) Sistemas policiclicos de 2-amino-dihidrotiazol, procedimiento para preparacion del medicamento y su empleo como medicamento
ATE84720T1 (de) Verwendung von adenosinderivaten zur herstellung von arzneimitteln mit immunstimulierender wirkung.
DE50000430D1 (de) Verfahren zur Herstellung von 2,3,5-Trimethylhydrochinondiestern

Legal Events

Date Code Title Description
8364 No opposition during term of opposition